<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109224">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01855464</url>
  </required_header>
  <id_info>
    <org_study_id>UKW-TCH-2013-001</org_study_id>
    <secondary_id>German Research Foundation</secondary_id>
    <nct_id>NCT01855464</nct_id>
  </id_info>
  <brief_title>Wedge Resection or Parietal Pleurectomy for the Treatment of Recurrent Pneumothorax (WOPP)</brief_title>
  <acronym>WOPP</acronym>
  <official_title>Pulmonary Wedge Resection Plus Parietal Pleurectomy (WRPP) Versus Parietal Pleurectomy (PP) for the Treatment of Recurrent Primary Pneumothorax</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wuerzburg University Hospital</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary spontaneous pneumothoraces (PSP) represent a significant public health problem,
      occurring in young healthy subjects without pre-existing lung disease or precedent medical
      intervention or trauma with a reported incidence of up to 18-28/100 000 per year. PSP
      treatment often requires thoracic surgery to restore lung expansion and to prevent de novo
      lung collapse. Despite the presence of elaborated guidelines by the British Thoracic Society
      (BTS) postulating apical wedge resection of the lung and total parietal pleurectomy (WRPP),
      the majority of German hospitals gathered experience especially in limiting surgery to
      cost-saving partial apical parietal pleurectomy or yet apical pleural abrasion (PP). Until
      today, hardly any reliable data exist to analyze and compare the varying treatment
      approaches regarding efficacy and efficiency. In this randomized, multi-centric clinical
      trial, both treatment approaches will be compared. For this purpose, candidates for surgery
      will be randomized into one of the two treatment groups after informed consent has been
      obtained. Patients will be followed for 2 years by the participating centres to be able to
      evaluate the long-term effect of the surgical interventions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The trial will be conducted at the major thoracic surgery units in Germany. Each centre can
      include patients on the basis of the presence of a PSP and the inclusion and exclusion
      criteria.

      After informed consent has been obtained from the study participants, each has to fill out
      the standardized short-form health survey (SF-36) questionnaire and the visual analogue
      scale (VAS) to determine baseline parameters for the (current) state of health and pain
      level.Randomization into the two interventional groups is carried out before surgery.

      Patients are operated according to good clinical practice either by pleurectomy alone (PP)
      or total parietal pleurectomy with apical wedge resection of the pulmonary apex (WRPP).
      Procedure related parameters (like operation time, applied suture materials including
      staplers) are documented.

      The postoperative care is subject to each participating centre's standards. The
      postoperative course is evaluated (mortality, morbidity, duration of tube drainage,
      re-interventions or operations, length of stay, need for blood substitutions).

      To evaluate the long term effect of the surgical intervention, all study participants are
      followed for 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Recurrence rate of primary pneumothorax following VAT surgery</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients are followed to identify all incidents of recurrent lung collapse following VAT surgery. Suspected recurrences will be confirmed by chest X-ray.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative morbidity</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>costs of treatment</measure>
    <time_frame>up to 30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Pneumothorax</condition>
  <condition>Recurrent Pneumothorax</condition>
  <arm_group>
    <arm_group_label>wedge resection+parietal pleurectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgical treatment includes parietal pleurectomy and wedge resection of the tip of the lung.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>parietal pleurectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical therapy is limited to parietal pleurectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>wedge resection</intervention_name>
    <description>Complementary to parietal pleurectomy lung tissue is resected.</description>
    <arm_group_label>wedge resection+parietal pleurectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>parietal pleurectomy</intervention_name>
    <description>The parietal pleura is resected for treating primary pneumothorax.</description>
    <arm_group_label>wedge resection+parietal pleurectomy</arm_group_label>
    <arm_group_label>parietal pleurectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  recurrence of a primary pneumothorax

          -  persistent primary pneumothorax

          -  patient preference (in primary events)

        Exclusion Criteria:

          -  presence of a pulmonal fistula

          -  underlying lung disease

          -  previous thoracic surgery (except tube thoracostomy)

          -  previous pleurodesis

          -  conversion thoracotomy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thorsten Walles, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Wuerzburg University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thorsten Walles, MD</last_name>
    <phone>+49 (0)931 201</phone>
    <phone_ext>33001</phone_ext>
    <email>Walles_T.htc@klinik.uni-wuerzburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jens Neudecker, MD</last_name>
    <phone>+ 49 (0)30 450</phone>
    <phone_ext>522125</phone_ext>
    <email>Jens.Neudecker@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86009</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ludwig Lampl, MD</last_name>
      <phone>+49 (0)821 400</phone>
      <phone_ext>4571</phone_ext>
      <email>oa-buero@klinikum-augsburg.de</email>
    </contact>
    <investigator>
      <last_name>Ludwig Lampl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vivantes Thoraxzentrum</name>
      <address>
        <city>Berlin</city>
        <zip>12351</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Eggeling, MD</last_name>
      <phone>+49 (0)30 130 14</phone>
      <phone_ext>2062</phone_ext>
      <email>thoraxchirurgie@vivantes.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Eggeling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DRK Kliniken Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13359</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul Schneider, MD</last_name>
      <phone>+49 80)30 3035</phone>
      <phone_ext>6405</phone_ext>
      <email>p.schneider@lungenzentrum-berlin.info</email>
    </contact>
    <investigator>
      <last_name>Paul Schneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelische Lungenklinik Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gunda Leschber, MD</last_name>
      <phone>+49 (0)30 94802</phone>
      <phone_ext>102</phone_ext>
      <email>Gunda.Leschber@elk-berlin.de</email>
    </contact>
    <investigator>
      <last_name>Gunda Leschber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jens Neudecker, MD</last_name>
      <phone>+49 (0)30 450 522</phone>
      <phone_ext>011</phone_ext>
      <email>Jens.Neudecker@charite.de</email>
    </contact>
    <investigator>
      <last_name>Jens Neudecker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Horia Sirbu, MD</last_name>
      <phone>+49 (0)9131 85</phone>
      <phone_ext>32047</phone_ext>
      <email>Horia.Sirbu@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Horia Sirbu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oliver Oster, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernward Passlick, MD</last_name>
      <phone>+49 (0)761 270</phone>
      <phone_ext>2455</phone_ext>
      <email>bernward.passlick@uniklinik-freiburg.de</email>
    </contact>
    <investigator>
      <last_name>Bernward Passlick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emanuel Palade, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Großhansdorf</name>
      <address>
        <city>Großhansdorf</city>
        <zip>22927</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Kugler, MD</last_name>
      <phone>+49 (0)4102 601</phone>
      <phone_ext>2201</phone_ext>
      <email>c.kugler@lungenclinic.de</email>
    </contact>
    <investigator>
      <last_name>Christian Kugler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nina Städtler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hans Hoffmann, MD</last_name>
      <phone>+49 (0)6221 396</phone>
      <phone_ext>1100</phone_ext>
      <email>hans.hoffmann@urz.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Hans Hoffmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lungenklinik Köln Merheim</name>
      <address>
        <city>Köln</city>
        <zip>51109</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erich Stoelben, MD</last_name>
      <phone>+49 (0)221 8907</phone>
      <phone_ext>8640</phone_ext>
      <email>StoelbenE@kliniken-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Erich Stoelben, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Bekkers, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik Löwenstein</name>
      <address>
        <city>Löwenstein</city>
        <zip>74245</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Gräter, MD</last_name>
      <phone>+49 (0)7130 15</phone>
      <phone_ext>4203</phone_ext>
      <email>chirurgie@klinik-loewenstein.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Gräter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LMU München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rudolf Hatz, MD</last_name>
      <phone>+49 (0)89 85 791</phone>
      <phone_ext>4201</phone_ext>
      <email>r.hatz@asklepios.com</email>
    </contact>
    <contact_backup>
      <last_name>Hauke Winter, MD</last_name>
      <phone>+49 (0)89 7095</phone>
      <phone_ext>0</phone_ext>
      <email>hauke.Winter@med.uni-muenchen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Rudolf Hatz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hauke Winter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thoraxzentrum Bezirk Unterfranken</name>
      <address>
        <city>Münnerstadt</city>
        <zip>97702</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Boris Kardziev, MD</last_name>
      <phone>+49 (0)9733 62</phone>
      <phone_ext>3700</phone_ext>
      <email>b.kardziev@tzbu.de</email>
    </contact>
    <investigator>
      <last_name>Boris Kardziev, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hans Hofmann, MD</last_name>
      <phone>+49 (0)941 944</phone>
      <phone_ext>9801</phone_ext>
      <email>hans-stefan.hofmann@klinik.uni-regensburg.de</email>
    </contact>
    <investigator>
      <last_name>Hans-Stefan Hofmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Robert Bosch Krankenhaus</name>
      <address>
        <city>Stuttgart</city>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Godehard Friedel, MD</last_name>
      <phone>+49 7156 203</phone>
      <phone_ext>2240</phone_ext>
      <email>friedel@klinik-schillerhoehe.de</email>
    </contact>
    <contact_backup>
      <last_name>Stefanie Veit, MD</last_name>
      <phone>+49 7156 203</phone>
      <phone_ext>2231</phone_ext>
      <email>Stefanie.Veit@klinik-schillerhoehe.de</email>
    </contact_backup>
    <investigator>
      <last_name>Godehard Friedel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefanie Veit, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Enole Boedeker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Volker Steger, MD</last_name>
      <phone>+49 (0)7071 298</phone>
      <phone_ext>3365</phone_ext>
      <email>Volker.Steger@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Volker Steger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wuerzburg University Hospital</name>
      <address>
        <city>Wuerzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorsten Walles, MD FETCS</last_name>
      <phone>+49-931-201-</phone>
      <phone_ext>33016</phone_ext>
      <email>Walles_T@ukw.de</email>
    </contact>
    <investigator>
      <last_name>Thorsten Walles, MD FETCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://gepris.dfg.de/gepris/OCTOPUS/;jsessionid=E6A2D8650C043C03A91FE2EC2CE5C091?context=projekt&amp;id=209750507&amp;module=gepris&amp;task=showDetail</url>
    <description>Click here for information on German Research Foundation Grant</description>
  </link>
  <reference>
    <citation>Henry M, Arnold T, Harvey J; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of spontaneous pneumothorax. Thorax. 2003 May;58 Suppl 2:ii39-52. No abstract available.</citation>
    <PMID>12728149</PMID>
  </reference>
  <reference>
    <citation>Chan JW, Ko FW, Ng CK, Yeung AW, Yee WK, So LK, Lam B, Wong MM, Choo KL, Ho AS, Tse PY, Fung SL, Lo CK, Yu WC. Management of patients admitted with pneumothorax: a multi-centre study of the practice and outcomes in Hong Kong. Hong Kong Med J. 2009 Dec;15(6):427-33.</citation>
    <PMID>19966346</PMID>
  </reference>
  <reference>
    <citation>Gossot D, Galetta D, Stern JB, Debrosse D, Caliandro R, Girard P, Grunenwald D. Results of thoracoscopic pleural abrasion for primary spontaneous pneumothorax. Surg Endosc. 2004 Mar;18(3):466-71. Epub 2004 Feb 2. Review.</citation>
    <PMID>14752638</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>December 16, 2013</lastchanged_date>
  <firstreceived_date>May 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pneumothorax</keyword>
  <keyword>primary pneumothorax</keyword>
  <keyword>lung collapse</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumothorax</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
